400 Crossing Blvd.,Fourth Floor
Bridgewater , NJ, 08807

Rank

Rank Universe

Summary

The fund seeks capital appreciation in the long term by investing in companies outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in companies based in the United States and other developed markets, as well as in emerging a More

Link

Directors

Jan 12, 2024
  • Jason Lamin
  • Alexandra K. Lynn
  • R. Kelly Doherty
  • Jill R. Cuniff
  • Eric Rakowski
  • David R. Loevner
  • Charles W. Freeman, III
  • Carolyn N. Ainslie

Chief Compliance Officer

  • Brian D. Simon

Price

  • $ 43.9 ( -0.1 )
    Nov 4, 2024
    Last Close
  • Net Assets
  • $1B
    Mar 27, 2024
  • Holding
  • 62
    Sep 30, 2024
    More

  • 52-Week High/Low
  • $45.11 - $35.37
  • Turnover
  • 45%
  • Expense Ratio
  • 0.82%

Company Name

Holding

Vertex Pharmaceuticals Incorporated 4.57 %
Microsoft Corp. 4.52 %
Schneider Electric SE 4.45 %
Meta Platforms Inc 4.42 %
Alphabet Inc. 4.35 %
Amazon.com, Inc. 4.34 %
Northern Inst Fds 4.29 %
Thermo Fisher Scientific Inc 2.8 %
Netflix, Inc. 2.7 %
Alcon AG 2.45 %
More 2.45 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

-19.89%

5 Year

22.01%

Best

27.86%

2019

Worst

-30.01%

2022

Alpha

HLGZX S&P 500

Chart +